Literature DB >> 20600417

Chronic vagus nerve stimulation decreased weight gain, food consumption and sweet craving in adult obese minipigs.

D Val-Laillet1, A Biraben, G Randuineau, C H Malbert.   

Abstract

Chronic vagus nerve stimulation (VNS) is known to influence food intake and body weight in animals and humans. The aim of our work was to evaluate the effects of long-term VNS in adult obese minipigs. Eight minipigs were fed ad libitum a Western diet to cause obesity, after which half of the animals were implanted with bilateral vagal electrodes connected to constant current stimulators (2mA, 30Hz, 500-μs pulse, ON 30s, OFF 5min). The other animals were implanted with sham devices. Animals were weighed weekly and their daily consumption was measured. Still 14 weeks after surgery, VNS animals (70.3±3.3kg, P>0.10) did not significantly gain weight compared to sham animals (80.6±8.0kg, P<0.05). Furthermore, food consumption decreased in VNS animals (-18%, P<0.02) compared to sham animals (+1%, P>0.10). When subjected to a three-choice meal test (high-fat vs. high-carbohydrates vs. balanced diet), VNS animals decreased their sweet-food consumption compared to sham animals (P<0.05), and increased their balanced diet consumption in comparison to pre-surgery levels. Our results showed that chronic VNS decreased weight gain, food consumption and sweet craving in adult obese minipigs, which indicates that this therapy might be used to decrease appetite in the context of morbid obesity.

Entities:  

Mesh:

Year:  2010        PMID: 20600417     DOI: 10.1016/j.appet.2010.06.008

Source DB:  PubMed          Journal:  Appetite        ISSN: 0195-6663            Impact factor:   3.868


  42 in total

1.  Comments on the article: Occipital C1-C2 Neuromodulation Decreases Body Mass and Fat Stores and Modifies Activity of the Autonomic Nervous System in Morbidly Obese Patients--a Pilot Study.

Authors:  Radwan Kassir; Jean-Claude Barthelemy; Frederic Roche; Olivier Tiffet
Journal:  Obes Surg       Date:  2016-02       Impact factor: 4.129

2.  Neurogastroenterology: modification of basal brain metabolism and neuronal activity is an acquired feature of obesity.

Authors:  Natalie J Wood
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-03       Impact factor: 46.802

3.  Electroceutical Targeting of the Autonomic Nervous System.

Authors:  Charles C Horn; Jeffrey L Ardell; Lee E Fisher
Journal:  Physiology (Bethesda)       Date:  2019-03-01

Review 4.  The Role of the Vagal Nucleus Tractus Solitarius in the Therapeutic Effects of Obesity Surgery and Other Interventional Therapies on Type 2 Diabetes.

Authors:  Claudio Blasi
Journal:  Obes Surg       Date:  2016-12       Impact factor: 4.129

Review 5.  Neural control of energy balance: translating circuits to therapies.

Authors:  Laurent Gautron; Joel K Elmquist; Kevin W Williams
Journal:  Cell       Date:  2015-03-26       Impact factor: 41.582

Review 6.  The vagus nerve and the inflammatory reflex--linking immunity and metabolism.

Authors:  Valentin A Pavlov; Kevin J Tracey
Journal:  Nat Rev Endocrinol       Date:  2012-12       Impact factor: 43.330

Review 7.  Effects of vagal neuromodulation on feeding behavior.

Authors:  Nicole A Pelot; Warren M Grill
Journal:  Brain Res       Date:  2018-02-07       Impact factor: 3.252

Review 8.  Role of the vagus nerve in the development and treatment of diet-induced obesity.

Authors:  Guillaume de Lartigue
Journal:  J Physiol       Date:  2016-05-29       Impact factor: 5.182

Review 9.  The Vagus Nerve in Appetite Regulation, Mood, and Intestinal Inflammation.

Authors:  Kirsteen N Browning; Simon Verheijden; Guy E Boeckxstaens
Journal:  Gastroenterology       Date:  2016-12-15       Impact factor: 22.682

10.  Vagal Blocking for Obesity Control: a Possible Mechanism-Of-Action.

Authors:  Helene Johannessen; David Revesz; Yosuke Kodama; Nikki Cassie; Karolina P Skibicka; Perry Barrett; Suzanne Dickson; Jens Holst; Jens Rehfeld; Geoffrey van der Plasse; Roger Adan; Bård Kulseng; Elinor Ben-Menachem; Chun-Mei Zhao; Duan Chen
Journal:  Obes Surg       Date:  2017-01       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.